What is nayzilam for?

What is Nayzilam prescribed for?

Nayzilam is a nasal spray version of midazolam used to treat seizure clusters in patients 12 and older. It works quickly when given through the nose to stop prolonged or repeated seizures that happen in a series. Patients or caregivers can self-administer it outside of a hospital setting.

What happens when you use Nayzilam?

Midazolam binds to GABA receptors in the brain to calm overactive electrical activity that causes seizures. The nasal route lets the drug reach the brain almost as fast as injection, but without needing IV access. It typically stops a seizure cluster within minutes.

How does Nayzilam compare with Diastat?

Diastat uses diazepam delivered rectally. Nayzilam offers a more convenient nasal route that is easier to administer by caregivers. Both drugs belong to the benzodiazepine class, but midazolam in Nayzilam has a faster onset and shorter duration.

Can Nayzilam be used for other conditions?

Nayzilam is FDA-approved only for seizure clusters. Off-label use for anxiety or sedation occurs occasionally, but doctors do not routinely recommend es for those purposes outside of hospital settings.

When does Nayzilam patent expire?

The patent on Nayzilam expires in 2034. Biosimilars and generics cannot enter the market before then [1].